Skip to main content
    N

    Nephros Inc (NEPH)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $2.90
    -0.10 (-3.33%)

    Market Cap: $32.61M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Nephros Inc (NEPH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Nephros (NEPH) has a market cap of $32.61M and an enterprise value of $28.41M. Revenue grew 20.36% over the last 12 months from the 12 months before. It holds $4.20M more cash than debt, 12.87% of its market cap.

    Total Valuation

    Enterprise value is 12.87% below the market cap, as cash exceeds debt.

    Market Cap$32.61M
    Enterprise Value$28.41M
    Latest price (Nov 17, 2026)$2.90

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.06% in the quarter ended Sep 30, 2026 and grew 1.50% a year over 2 years.

    Shares Outstanding10.86M
    Shares Change (YoY)+2.37%
    Shares Change (QoQ)+0.06%
    Share Count Growth (2Y CAGR)+1.50%

    Valuation Ratios

    Sales and book value multiples are 1.5x and 2.5x.

    P/E Ratio22.3x
    Forward P/E16.4x
    P/S Ratio1.5x
    Forward P/S1.5x
    P/B Ratio2.5x
    P/TBV Ratio2.8x
    PEG Ratio0.5

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 14.6x EBITDA.

    EV / Earnings14.8x
    EV / Sales1.3x
    EV / EBITDA14.6x

    Price Statistics

    The stock is down 34.09% over 52 weeks and trades 20.11% below its 50-day average.

    Beta (1Y)0.95
    52-Week Change-34.09%
    1-Month Change-21.20%
    3-Month Change-39.08%
    6-Month Change-20.11%
    5-Year Change-59.57%
    Total Return (1Y)-34.09%
    Total Return (3Y CAGR)+12.26%
    Total Return (5Y CAGR)-17.16%
    Return vs SPY (1Y)-58.35%
    Max Drawdown (1Y)-51.94%
    Max Drawdown (3Y)-65.06%
    Sharpe Ratio (1Y)-0.78
    Correlation with SPY (1Y)0.16
    50-Day Average$3.63
    200-Day Average$3.58
    52-Week Range$2.66 to $6.42
    RSI (14 Days)38.8
    Average Volume (20 Days)75.19K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.50x current liabilities, and total debt is 0.03x shareholder equity.

    Current Ratio5.50x
    Quick Ratio3.45x
    Debt / Equity0.03x
    Debt / EBITDA0.19x
    Interest Coverage1068.00x

    Returns and Efficiency

    Return on invested capital is 10.76% over the last 12 months, against a 5-year average of -5.43%.

    Return on Equity (ROE)15.29%
    Return on Assets (ROA)12.54%
    Return on Invested Capital (ROIC)10.76%
    ROE (5Y Average)-33.28%
    ROA (5Y Average)-18.08%
    ROIC (5Y Average)-5.43%
    Asset Turnover1.51x
    Inventory Turnover1.79x
    Receivables Turnover5.62x
    Cash Conversion Cycle208 days

    Taxes

    Income tax took 0.68% of pretax income over the last 12 months.

    Income Tax (TTM)$13.00K
    Effective Tax Rate0.68%

    Scores

    NEPH has an Altman Z-Score of -3.43, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score-3.43
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $21.58M over the last 12 months.

    Revenue$21.58M
    Revenue Growth (YoY)+20.36%
    Gross Profit$13.07M
    Operating Income$1.83M
    Pretax Income$1.92M
    Net Income$1.92M
    Reported EPS (TTM)$0.13

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 82.03% of the $15.30M in total assets.

    Cash and Equivalents$4.55M
    Total Debt$348.00K
    Net Cash$4.20M
    Net Cash Per Share$0.39
    Working Capital$10.85M
    Shareholder Equity$12.55M
    Book Value Per Share$1.16
    Tangible Book Value$11.36M
    Tangible Book Per Share$1.05
    Total Assets$15.30M
    Total Liabilities$2.76M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$910.00K
    FCF Per Share-$0.08
    Depreciation and Amortization$118.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 8.48%, against a 5-year average of -16.07%.

    Gross Margin60.55%
    Operating Margin8.48%
    Pretax Margin8.92%
    Net Margin8.89%
    Gross Margin (5Y Average)57.01%
    Operating Margin (5Y Average)-16.07%
    Net Margin (5Y Average)-22.65%

    Growth

    Revenue grew 23.50% a year over 3 years.

    Revenue Growth (3Y CAGR)+23.50%
    Revenue Growth (5Y CAGR)+17.02%
    Book Value Per Share Growth (2Y CAGR)+8.32%
    Tangible Book Per Share Growth (2Y CAGR)+11.36%

    Revenue and profit by year

    Dividends and Yields

    NEPH does not pay a dividend.

    Earnings Yield4.48%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-9 reverse split on Jul 10, 2019.

    Last Split DateJul 10, 2019
    Split TypeReverse split
    Split Ratio1:9

    Peer Position

    Against 11 similar companies, NEPH has the 8th highest P/S.

    P/S Ratio1.5x vs 2.9x median
    ROIC10.76% vs -10.25% median
    Revenue Growth (Trailing 4 Quarters, YoY)+20.36% vs +3.14% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 17.32% and EPS growth at 41.42% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+17.32%
    EPS Growth Forecast (2Y CAGR)+41.42%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NEPH

    What is NEPH's market cap?

    Nephros has a market cap of $32.61M. Its enterprise value, which adds debt and subtracts cash, is $28.41M.

    What is NEPH's P/E ratio?

    Nephros has a trailing P/E ratio of 22.3x and a forward P/E of 16.4x.

    How many shares of NEPH are outstanding?

    Nephros has 10.86M shares outstanding. The count is up 2.37% from a year earlier.

    Does NEPH pay a dividend?

    No. Nephros does not pay a dividend.

    How much debt does NEPH have?

    Nephros has $348.00K of total debt and $4.55M of cash and equivalents, a net cash position of $4.20M.